US pharma major Eli Lilly has launched in India its eagerly awaited diabetes and obesity drug Mounjaro tripeptide Read ahead ...
10 小时on MSN
With the growing demand for weight-loss solutions, many individuals in India have resorted to purchasing obesity drugs from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果